Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Med. clín (Ed. impr.) ; 152(2): 55-58, ene. 2019. graf, tab
Article in Spanish | IBECS | ID: ibc-181820

ABSTRACT

Introducción y objetivo: La hipoterapia se está utilizando como un método muy prometedor en el tratamiento físico de los pacientes con esclerosis múltiple (EM). Material y método: Se realizó un ensayo clínico abierto comparativo pre-post con intervención de hipoterapia en pacientes de EM (n=6), no aleatorizado y con presencia de grupo control (n=4), de 6 meses de duración. El estudio fue realizado por la Fundación MHG. Resultados: Se obtuvo una mejoría estadísticamente significativa en el grupo terapia en la espasticidad pre y postestudio medida mediante la escala de Ashworth modificada (p=0,01); una mejoría estadísticamente significativa en el impacto de la fatiga (p<0,0001) medida con la FIS, en la percepción general de la salud en la escala de calidad de vida urinaria (p=0,033) medida mediante el KHQ, y en las subescalas 2, 3 y 4 del MSQOL-54 (p=0,011). En el grupo control no se produjo ninguna mejoría en ninguna de las escalas. Conclusiones: Este estudio refuerza la literatura existente que soporta la hipoterapia como una intervención adecuada para pacientes de EM. Se precisan futuros trabajos con muestras más grandes, presencia de grupo control y el cegado a nivel del investigador


Introduction and objective: Hippotherapy is being used as a promising method in the physical treatment of multiple sclerosis (MS). Material and method: Comparative open clinical pre-post study into hippotherapy intervention during a 6-month period in patients with MS (n=6). Not randomised and with control group (n=4). The study was performed by MHG Foundation. Results: A statistically significant improvement was observed in the therapy group in: spasticity pre-post measured by the modified Ashworth scale (P=.01). Statistically significant improvement in fatigue impact (P<.0001) measured with FIS; in general, perception of heath outcome in urinary quality of life scale KHQ (P=.033), and in subscales 2, 3 and 4 of MSQOL-54 (P=.011). Control group showed no improvement in any scale. Conclusions: This study reinforces current literature that supports hippotherapy as an adequate intervention for MS patients. Further studies with more participants, control groups and blinded research would be logical steps for future research in this field


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Equine-Assisted Therapy/methods , Multiple Sclerosis/therapy , Quality of Life , Muscle Spasticity , Gait , Depression/therapy , Fatigue/therapy , Data Analysis , 25783
2.
Med Clin (Barc) ; 152(2): 55-58, 2019 01 18.
Article in English, Spanish | MEDLINE | ID: mdl-29680460

ABSTRACT

INTRODUCTION AND OBJECTIVE: Hippotherapy is being used as a promising method in the physical treatment of multiple sclerosis (MS). MATERIAL AND METHOD: Comparative open clinical pre-post study into hippotherapy intervention during a 6-month period in patients with MS (n=6). Not randomised and with control group (n=4). The study was performed by MHG Foundation. RESULTS: A statistically significant improvement was observed in the therapy group in: spasticity pre-post measured by the modified Ashworth scale (P=.01). Statistically significant improvement in fatigue impact (P<.0001) measured with FIS; in general, perception of heath outcome in urinary quality of life scale KHQ (P=.033), and in subscales 2, 3 and 4 of MSQOL-54 (P=.011). Control group showed no improvement in any scale. CONCLUSIONS: This study reinforces current literature that supports hippotherapy as an adequate intervention for MS patients. Further studies with more participants, control groups and blinded research would be logical steps for future research in this field.


Subject(s)
Equine-Assisted Therapy , Multiple Sclerosis/therapy , Adult , Depressive Disorder/etiology , Depressive Disorder/therapy , Fatigue/etiology , Fatigue/therapy , Female , Gait Disorders, Neurologic/etiology , Gait Disorders, Neurologic/therapy , Humans , Male , Middle Aged , Multiple Sclerosis/complications , Multiple Sclerosis/psychology , Muscle Spasticity/etiology , Muscle Spasticity/therapy , Pelvic Floor/physiopathology , Pilot Projects , Quality of Life , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...